Trial Details
TERMINATEDBasic Information
| Clinical ID | c2614 |
|---|---|
| Identifier | NCT03221166 |
| Trial Title | Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Thalidomide|DRUG: Infliximab |
Participant Information
| Sponsor | IRCCS Burlo Garofolo |
|---|---|
| City | Campania |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-02-27 |
|---|---|
| Primary Completion Date | 2020-07-31 |
| Completion Date | 2020-07-31 |